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Background: Stress-induced cardiomyopathy (SIC) has gained increasing attention worldwide and is characterized
by extensive ventricular akinesis, Beta-blockers and angiotensin-converting enzyme inhibitors (ACEIs) are the main
treatments for SIC patients. The pharmacological mechanism of action of beta-blockers results in the inhibition
of the biological effects of catecholamines. However, the mechanism of action of ACEIs in the treatment of
cardiomyopathy is not known. Our aim is to assess changes in levels of angiotensin II, angiotensin-II receptors and
ACE responses to SIC.
Methods: A model of inverted SIC was established in rabbits by vagal electrical stimulation. The serum concentration
of angiotensin II and angiotensin (1-7) was detected by enzyme-linked immunosorbent assay. Expression of
angiotensin-II receptors was measured by Western blotting and real-time reverse transcription-polymerase chain
reaction (RT-PCR), with localization detected by immunofluorescent staining. ACE-II expression in the myocardium was
measured by Western blotting.
Results: From one day after vagal stimulation, concentrations of angiotensin II were significantly higher in the
experimental group than those in the control group (P <0.05). Stress induced a time-dependent decrease in angiotensin
subtype-1 (AT1) expression and a time-dependent increase in AT2 expression only in the apical portion of the
myocardium. From three days after vagal stimulation, angiotensin (1-7) levels were significantly lower in the experimental
group compared with the control group (P <0.05). Expression of the ACE-II protein was significantly downregulated in
the experimental group compared with the control group from three days after vagal stimulation (P <0.05).
Conclusions: Expression of angiotensin II, its receptors, ACE-II and angiotensin (1-7) was altered in response to SIC. The
renin-angiotensin system could represent a therapeutic target in the prevention of SIC.
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Angiotensin (1-7)Background
Stress-induced cardiomyopathy (SIC; also named Takotsubo
cardiomyopathy) was first described in Japan in 1991 [1].
Stress factors can be sudden psychological, physical or
emotional. SIC has gained increasing attention worldwide
and is a well-recognized cause of acute heart failure, lethal
arrhythmias and ventricular rupture [2]. SIC is character-
ized by extensive ventricular akinesis involving apical* Correspondence: grw771210@163.com
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out significant lesions in coronary arteries.
Recently, evidence has shown that serum levels of cate-
cholamines in SIC patients one to two days after presenta-
tion are higher than in patients with myocardial infarction
with pulmonary edema, and that epinephrine levels return
to those seen in those with myocardial infarction only
after seven to nine days [3]. Experimental studies reported
the catecholamine intoxication is the main etiology of SIC
[4, 5], but the mechanism of action is not clear.
SIC patients have an excellent prognosis as well as absent
or minimal residual cardiac impairment, and left ventricularThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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entation [6]. At present, beta-blockers and angiotensin-
converting enzyme inhibitors (ACEIs) are the main
treatments for SIC patients [3, 7, 8]. The pharmaco-
logical mechanism of action of beta-blockers results in
the inhibition of the biological effects of catecholamines
[9]. However, the mechanism of action of ACEIs in the
treatment of cardiomyopathy is not known. The target of
ACEIs is angiotensin-converting enzyme 1 (the main func-
tion of which is to convert angiotensinogen to angiotensin
II). Angiotensin II contains peptides that are involved in
the renin-angiotensin system (RAS) and which regulate
cellular and physiological responses in the cardiovascular
system. Angiotensin II is also implicated in the patho-
physiological processes related to myocardial remodeling
[10, 11]. Angiotensin II activates several nuclear transcrip-
tion factors (such as signal transducer and activator of
transcription (STAT) and cyclic adenosine monophosphate
(cAMP) response element-binding (CREB) protein) by
promoting fibroblast proliferation that leads to myocardial
remodeling [12,13].
Angiotensin II signals through seven transmembrane-
spanning G protein-coupled receptors that are character-
ized into angiotensin subtype-1 (AT1) and angiotensin
subtype-2 (AT2) based on their selective affinity for pep-
tide and non-peptide ligand [14]. Northern blotting and
reverse transcription-polymerase chain reaction (RT-PCR)
analyses have been used to identify AT1 and AT2 mRNA
in many cells and tissues (including the human myocar-
dium). Pharmacological studies have revealed that the
AT1 subtype mediates responses to angiotensin II caused
by the release of aldosterone and epinephrine [15]. One
study showed that expression of angiotensin-II receptors
changes in response to stress [16]. Nevertheless, few stud-
ies have focused on the association between angiotensin II
and its receptors with SIC.
In the present study, we assessed changes in angiotensin
II, angiotensin-II receptors, and angiotensin-converting
enzyme (ACE) responses to SIC from in vivo studies using
a rabbit model of SIC.
Methods
All studies conformed to the Guide for the Care and Use
of Laboratory Animals (US National Institutes of Health,
publication number 85-23, revised 1996; Additional file 1:
Figure S1).
Reagents
Anti-AT1 and anti-AT2 receptor antibodies were pur-
chased from Santa Cruz Biotechnology (Santa Cruz,
California, United States). A one-step RT-PCR kit was ob-
tained from TaKaRa (TaKaRa, Shiga, Japan). Angiotensin
II, angiotensin (1-7) and ACE-II enzyme-linked immuno-
assay (ELISA) kits (all from rabbits) were obtained fromBlue Gene Chemical Company (Blue Gene Chemical
Company, Shanghai, China). Tween 20, Nonidet 40 (NP-
40), aprotinin, leupeptin, phenylmethylsulfonyl fluoride
(PMSF) and dithiothreitol (DTT) were purchased from
Sigma-Aldrich (Sigma, St. Louis, United States).
In vivo model of stress-induced cardiomyopathy
Experimental procedures were designed according to those
of Takato et al. [17]. Female rabbits (weighing appro-
ximately 2 kg; General Hospital of Chengdu Military
Command, Kunming, China) were anesthetized (100 mg/kg
ketamine, 5 mg/kg xylazine(Aibixin Chemical Company,
Shanghai, Chin), intramuscular injection). Electrical stimu-
lations of 50-Hz intensity and l-ms duration with stepwise
increases in voltage from 0.1 to 1.0 V were applied to the
right cervical intact vagus under electrocardiographic moni-
toring. Stimulation was maintained for 1 minute with a
pause of 2 minutes between stimulations for approximately
1 hour. The sham group did not have electrical stimula-
tions. At 1, 3, 7 and 14 days after vagal stimulation, animals
were anesthetized and hearts removed.
Western blotting
Proteins were extracted as described [18]. 100 ug of protein
were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (10% polyacrylamide gel (Xibao Chemical
Company, Shanghai, China)). Proteins were transferred
onto polyvinylidene difluoride membranes by electroblot-
ting for 3 hours at 150 mA. Membranes were blocked in
5% non-fat milk solution in Tris-buffered saline with 0.5%
Tween 20 (Sigma, St. Louis, United States). Membranes
were allowed to react with primary antibodies (respectively
AT1 and AT2 antibody). Detection of specific proteins was
done by enhanced chemiluminescence following manufac-
turer instructions. Densitometric signals were quantified
using Quantity One software (BioRad, Hercules, California,
United States).
RNA isolation and real-time reverse transcription-
polymerase chain reaction
Total RNA was isolated with TRIzol™ reagent according to
manufacturer protocols (Sigma, St. Louis, United States).
Total RNA was reverse-transcribed into cDNA. The result-
ant cDNA was amplified by SYBR Green 1 fluorescence
real-time RT-PCR. The PCR reaction was monitored dir-
ectly using the Bioer FQD-66A sequence detection system
(Bioer Company, Hangzhou, China).
The primers for AT1 were 5′-TTTGGGAACAGCTTGG
CGGT-3′ (forward) and 5′-GCCAGCCAGCAGCCAAA
TAA-3′ (reverse). The primers for AT2 were 5′-AGG
TTTCCAGCATTTACATC-3′ (forward) and 5′-GTCAC
CAGCCAACGCTATC-3′ (reverse). The primers for β-
actin were 5′-AGGAAGGAGGGCTGGAACA-3′ (forward)
and 5′-CCCATCTACGAGGGCTACGC-3′ (reverse).
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using 35 cycles. The PCR profile used for AT1 amplifica-
tion was 30 s of denaturation at 94°C, 30 seconds of an-
nealing at 57°C, and 1.5 minutes of extension at 72°C.
The PCR profile used for AT2 amplification was 30 sec-
onds of denaturation at 94°C, 30 seconds of annealing at
60°C, and 1.5 minutes of extension at 72°C. The profile
for β-actin amplification was: 30 s of denaturation at
94°C, 30 seconds of annealing at 57°C, and 1.5 minutes
of extension at 72°C. Results were expressed as the
mean ± SD for relative expression levels.Immunofluorescence
Apical tissue was removed and used for detection of AT1
and AT2 by immunofluorescence. For staining, sections
were fixed in acetone for 10 minutes, air dried, and rehy-
drated with phosphate-buffered saline (PBS) before in-
cubation in serum-free Protein Block (Dako, Glostrup,
Denmark) for 30 minutes. Sections were stained with anti-
body diluted in 1% blocking reagent/0.3% Triton X-100 in
PBS overnight before being washed in Tris-NaCl-Tween-
Buffer (TNT) wash buffer (Tris-HCl, pH 7.5, 0.15 mol/L
NaCl, and 0.05% Tween 20 (Sigma, St. Louis, United
States). Sections incubated with an isotype-matched control
antibody were used as the negative control. Subsequently,
sections were incubated with fluorescein isothiocyanate-
goat anti-mouse IgG(Zhongshan, Beijing, China) for
30 minutes before washing. Nuclei were stained with
4′,6-Diamidino-2-phenylindole dihydrochloride. Images
were obtained using a Confocal Laser Scanning Micro-
scope (TCS SP5; Leica, Wetzlar, Germany).Figure 1 Changes in plasma levels of angiotensin II in response to str
ELISA. Concentrations of angiotensin II were significantly higher in the exp
vagal stimulation. Seven days after vagal stimulation, the concentration of
0 days after vagal stimulation. Results are the mean ± SEM of six experimen
vagal stimulation.ELISA
The concentration of angiotensin II and angiotensin (1-7)
in serum samples was detected by ELISA according to
specifications in the kit (Sigma, St. Louis, United States).
Statistical analyses
Results are the mean ± SEM. SPSS version 13.0 (SPSS,
Chicago, Illinois, United States) was used for statistical
analyses. The Student t-test was employed to compare
two groups. Analysis of variance (ANOVA) was used with
the Tukey multiple comparison test for multiple groups. A
P value of <0.05 was considered significant.
Results
Change in plasma levels of angiotensin II in response to stress
At 0, 1, 3, 7 and 14 days after vagal stimulation, the plasma
of rabbits in control and experimental groups was ex-
tracted, and the concentration of angiotensin II measured
by ELISA. From 1 day after vagal stimulation, the con-
centration of angiotensin II increased gradually in the ex-
perimental group. At seven days, the concentration of
angiotensin II reached its peak (1.353 ± 0.003 ng/mL), and
was significantly higher than that 0 days after vagal stimu-
lation (P <0.05). Meanwhile, the concentrations of angio-
tensin II were significantly higher in experimental group
than those in the control group from one day after vagal
stimulation (P <0.05). Detailed data was listed in Figure 1.
Expression of AT1 and AT2 mRNA and protein in a model
of acute cardiomyopathy
We next examined the effect of stress on angiotensin re-
ceptor mRNA and protein expression. From one day afteress. The plasma concentration of angiotensin II was measured by
erimental group than those in the control group from 0 days after
angiotensin II reached its peak, and was significantly higher than at
ts. *P <0.05 versus control groups #P < 0.05 versus at day 0 after
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crease in the expression of AT1 mRNA and protein in the
apical portion. Compared to that in basal portion, the ex-
pression of AT1 mRNA and protein significantly downreg-
ulated in the apical portion from three days after vagal
stimulation (P <0.05). Expression of apical AT1 mRNA
and protein in the experimental group was significantly
lower than that in the control group (P <0.05) (Figure 2A).
Conversely, expression of AT2 mRNA and protein in the
apical portion was increased by stress from one day after
vagal stimulation. Compared with that in the basal portion
of the experimental group and the apical portion of the
control group, expression of AT2 mRNA and protein was
upregulated significantly in the apical portion of the ex-
perimental group (P <0.05) (Figure 2B).
Localization of AT1 and AT2 in basal and apical portions
upon response to stress
Immunofluorescent staining was undertaken to deter-
mine the localization of AT1 and AT2 in basal and apicalFigure 2 Real-time RT-PCR and Western blotting for expression of AT
representative of three different experiments. Compared with that in the a
experimental group, expression of AT1 mRNA and protein was downregula
three days after vagal stimulation, but expression of AT2 mRNA and protein
stimulation. Results are the mean ± SEM of three experiments. *P <0.05 vers
experimental group.portions of the experimental group seven days after vagal
stimulation. Clear immunoreactivity for AT1 and AT2 was
detected in scattered cells of the myocardium in basal and
apical portions. In addition, compared with those in the
myocardium of the basal portion, an increased number of
AT1-positive cells and a decreased number of AT2-
positive cells was observed in the myocardium of the ap-
ical portion (Figure 3).
Change in plasma levels of angiotensin (1-7) and ACE-II
protein in a model of acute cardiomyopathy
At 0, 1, 3, 7 and 14 days after vagal stimulation, the
plasma of rabbits in control and experimental groups
was extracted, and the concentration of angiotensin (1-7)
measured by ELISA. From three days after vagal stimula-
tion, angiotensin (1-7) levels were significantly lower in
the experimental group compared with the control group
(P <0.05). When compared with 0 days after vagal stimula-
tion, the concentration of angiotensin (1-7) was signifi-
cantly lower at 3, 7 and 14 days (P <0.05) (Figure 4A).1 (A) and AT2 (B) mRNA and protein, respectively. Data are
pical portion of the control group and basal portion of the
ted significantly in the apical portion of the experimental group from
in the apical portion was upregulated from one day after vagal
us apical portion of the control group and basal portion of the
Figure 3 Immunofluorescent staining to determine the localization of AT1 and AT2 in basal and apical portions of the experimental
group seven days after vagal stimulation. A: Immunofluorescent staining of angiotensin subtype-1 (AT1) (green) and nucleus (blue) in the
myocardium. B: Immunofluorescent staining of angiotensin angiotensin subtype-2 (AT2) (green) and nucleus (blue) in the myocardium. Results
are from a single experiment but representative of three separate experiments. All bars represent 50 μm.
Xi et al. European Journal of Medical Research 2014, 19:54 Page 5 of 8
http://www.eurjmedres.com/content/19/1/54Apical tissue of the control group and experimental group
was collected, and levels of ACE-II protein measured by
Western blotting. Compared with that in the control
group, expression of ACE-II protein was downregulated
significantly in the experimental group from three days
after vagal stimulation (P <0.05) (Figure 4B).
Discussion
The RAS has been shown (clinically and experimentally)
to be associated with the progression and outcome of
cardiovascular diseases such as atherosclerosis, acute
coronary syndrome, cardiac hypertrophy and heart fail-
ure [19, 20]. Angiotensin II has been implicated in the
pathophysiological processes related to myocardial re-
modeling [11, 21]. The link that connects SIC and RAS
is not known.
In the context of former studies on cardiomyopathy
and the rennin angiotensin system, our study elicited
three main findings. Firstly, the concentration of angio-
tensin II increased gradually in the rabbit model of
inverted SIC by vagal stimulation. Secondly, expression
of apical AT1 mRNA and protein in the experimentalgroup was decreased significantly, but expression of AT2
mRNA and protein was upregulated significantly. Finally,
plasma levels of angiotensin (1-7) and ACE-II expression
were decreased in the rabbit model of inverted SIC.
Recently, epinephrine-induced cardiotoxicity has been
postulated to be involved in the pathogenesis of SIC [5,
22]. It is well established that angiotensin II can stimu-
late epinephrine release from the adrenal glands [15, 23].
The present study is the first to show that the plasma
concentration of angiotensin II increases gradually in
SIC. These data strongly suggest that angiotensin II and
its signaling pathway may be involved in the pathogen-
esis of SIC. Nevertheless, the underlying mechanism of
action merits further study.
Premer et al. revealed that the AT1 subtype mediates
the release of aldosterone and epinephrine as well as
pressor, dipsogenic and sodium-appetite responses to
angiotensin II in the brain [24]. We examined the effect
of stress on the expression of mRNA and proteins from
angiotensin receptors. The results showed that stress in-
duced a time-dependent decrease in the expression of
AT1 mRNA and protein in only the apical portion.
Figure 4 Change in plasma levels of angiotensin (1-7) and ACE-II protein iafter vagal stimulation. A, Angiotensin (1-7) levels were
measured by ELISA 0, 1, 3, 7 and 14 days after vagal stimulation. A, Angiotensin (1-7) levels were significantly lower in the experimental group
compared with the control group at 3, 7 and 14 days. Angiotensin (1-7) levels were significantly lower at 3, 7 and 14 days compared with 0 days.
Results are the mean ± SEM of six experiments. *P <0.05 versus control groups, #P <0.05 versus at day 0 after vagal stimulation. B, ACE-II protein in
the apical tissue of the control group and experimental group was measured by Western blotting. From three days after vagal stimulation,
expression of ACE-II protein was significantly lower in the experimental group than in the control group. Results are the mean ± SEM of three
experiments. *P <0.05 versus the control group.
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apical portion was increased by stress. Immunofluores-
cent staining showed AT1 and AT2 in scattered parts of
the myocardium. Izumi et al. also reported that expres-
sion of AT1 mRNA was significantly reduced, and that
of AT2 remarkably increased, in apical portions [16].
Several lines of evidences suggest that catecholamine
concentrations are increased by stress [25, 26]. Down-
regulation of expression of AT1 and upregulation ofexpression of AT2 in the apical portion of the myocar-
dium may be induced by excess epinephrine [16]. Data
have shown expression of AT1 and AT2 in the left ven-
tricle to be decreased in human heart failure, which is
different to the effect of stress on expression of AT1 and
AT2 [27]. AT2 mediates cardioprotection, so upregula-
tion of expression of AT2 in the apical portion of the
myocardium could (at least in part) influence the prog-
nosis of patients with SIC.
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been found to be present in the heart, kidney and other
tissues [28]. The bioactivity of ACE-II helps to catalyze
angiotensin II to angiotensin (1-7). Angiotensin (1-7) is
a cardiovascular-protective peptide with vasodilatory and
antiproliferative effects. ACE-II can increase the degrad-
ation of angiotensin II, thereby reducing the adverse ef-
fects of angiotensin II [29,30]. Our study is the first to
show that angiotensin (1-7) levels were significantly
lower in response to SIC. Expression of ACE-II proteins
was also significantly downregulated in the apical myo-
cardium in SIC, and is part of the cause of stress-
induced heart failure.
Conclusions
Expression of angiotensin II, its receptors, ACE-II and
angiotensin (1-7) was altered in response to SIC. The
renin-angiotensin system could represent a therapeutic
target in the prevention of SIC.
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Additional file 1: Figure S1. A model of stress-induced cardiomyopathy
was established in rabbits by vagal electrical stimulation according to the
method of Takato et al. [17]. Female rabbits (weighing approximately 2 kg;
General Hospital of Chengdu Military Command, Kunming, China) were
anesthetized (100 mg/kg ketamine, 5 mg/kg xylazine, intramuscular
injection). The right cervical vagus was exposed (A). Electrical stimulations of
50-Hz intensity and l-ms duration with stepwise voltage increases from 0.1
to 1.0 V were applied to the right cervical vagus under electrocardiographic
monitoring. Stimulation was maintained for 1 minute with a pause of 2
minutes between each stimulation for approximately 1 hour (B).
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